GSK2282512A (Quadrivalent Influenza Vaccine)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GSK2282512A (Quadrivalent Influenza Vaccine), covering 2016-04-12 to 2016-04-12. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine (GSK2282512A) Compared to Fluzone® Quadrivalent in Children 6 to 35 Months of Age [Phase 3]